(2S,3R)-ethyl 3-((S)-1,1-dimethylethylsulfinamido)-2-((diphenylmethylene)amino)-4,4,4-trifluorobutanoate | 1219366-63-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2S,3R)-ethyl 3-((S)-1,1-dimethylethylsulfinamido)-2-((diphenylmethylene)amino)-4,4,4-trifluorobutanoate
• 英文别名: ethyl (2S,3R)-3-(((S)-tert-butyl(hydroxy)-4-sulfanyl)amino)-2-((diphenylmethylene)amino)-4,4,4-trifluorobutanoate；ethyl (2S,3R)-2-(benzhydrylideneamino)-3-[[(S)-tert-butylsulfinyl]amino]-4,4,4-trifluorobutanoate
• CAS: 1219366-63-8
• 化学式: C₂₃H₂₇F₃N₂O₃S
• 分子量: 468.54
• InChiKey: LVIZZTGBJWWHNL-PAOLZVMYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  32
• 可旋转键数：
  10
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  87
• 氢给体数：
  1
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  (2S,3R)-ethyl 3-((S)-1,1-dimethylethylsulfinamido)-2-((diphenylmethylene)amino)-4,4,4-trifluorobutanoate 在 盐酸 作用下， 以 1,4-二氧六环 、 乙醇 为溶剂， 反应 1.0h， 生成 ethyl (2S,3R)-2,3-diamino-4,4,4-trifluorobutanoate
  参考文献：
  名称：

  [EN] ORGANIC COMPOUNDS FOR APPLICATIONS IN BACTERIAL INFECTIONS TREATMENT
  [FR] COMPOSÉS ORGANIQUES DESTINÉS À ÊTRE APPLIQUÉS DANS LE TRAITEMENT D'INFECTIONS BACTÉRIENNES

  摘要：

  本申请描述了对治疗、预防及/or改善人类疾病的有机化合物。

  公开号：

  WO2010031750A1
• 作为产物：
  描述：

  (S,E)-2-methyl-N-(2,2,2-trifluoroethylidene)propane-2-sulfinamide 、 二苯亚甲基甘氨酸乙酯 在 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 、 甲苯 为溶剂， 反应 1.0h， 以17%的产率得到(2S,3R)-ethyl 3-((S)-1,1-dimethylethylsulfinamido)-2-((diphenylmethylene)amino)-4,4,4-trifluorobutanoate
  参考文献：
  名称：

  Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC

  摘要：

  Over the past several decades, the frequency of antibacterial resistance in hospitals, including multidrug resistance (MDR) and its association with serious infectious diseases, has increased at alarming rates. Pseudomonas aeruginosa is a leading cause of nosocomial infections, and resistance to virtually all approved antibacterial agents is emerging in this pathogen. To address the need for new agents to treat MDR P. aeruginosa, we focused on inhibiting the first committed step in the biosynthesis of lipid A, the deacetylation of uridyldiphospho-3-O-(R-hydroxydecanoyl)-N-acetylglucosamine by the enzyme LpxC. We approached this through the design, synthesis, and biological evaluation of novel hydroxamic acid LpxC inhibitors, exemplified by 1, where cytotoxicity against mammalian cell lines was reduced, solubility and plasma-protein binding were improved while retaining potent anti-pseudomonal activity in vitro and in vivo.

  DOI：

  10.1021/acs.jmedchem.7b00377

文献信息

• [EN] ANTIBACTERIAL AGENTS<br/>[FR] AGENTS ANTIBACTÉRIENS
  申请人：ACHAOGEN INC

  公开号：WO2013170030A1

  公开（公告）日：2013-11-14

  Antibacterial compounds of formula (I) are provided, as well as stereoisomers and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of such compounds.

  提供了化学式（I）的抗菌化合物，以及其立体异构体和药用盐；包含这些化合物的药物组合物；通过给予这些化合物治疗细菌感染的方法；以及制备这些化合物的过程。
• [EN] ORGANIC COMPOUNDS FOR APPLICATIONS IN BACTERIAL INFECTIONS TREATMENT<br/>[FR] COMPOSÉS ORGANIQUES DESTINÉS À ÊTRE APPLIQUÉS DANS LE TRAITEMENT D'INFECTIONS BACTÉRIENNES
  申请人：NOVARTIS AG

  公开号：WO2010031750A1

  公开（公告）日：2010-03-25

  The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.

  本申请描述了对治疗、预防及/or改善人类疾病的有机化合物。
• ANTIBACTERIAL AGENTS
  申请人：Achaogen, Inc.

  公开号：US20150175530A1

  公开（公告）日：2015-06-25

  Antibacterial compounds of formula (I) are provided: as well as stereoisomers and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of such compounds.

  提供式(I)的抗菌化合物：以及其立体异构体和药物学上可接受的盐；包含这些化合物的制药组合物；通过给予这些化合物的途径来治疗细菌感染的方法；以及制备这些化合物的过程。
• ORGANIC COMPOUNDS AND THEIR USES
  申请人：Dobler Markus Rolf

  公开号：US20100120872A1

  公开（公告）日：2010-05-13

  The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
• US8372885B2
  申请人：——

  公开号：US8372885B2

  公开（公告）日：2013-02-12